Skip to main content
Clinical Trials/ACTRN12609000332224
ACTRN12609000332224
Completed
未知

In people with chronic obstructive pulmonary disease (COPD), does the use of a wheeled walker in the home and community change daily physical activity?

Dr. Sue Jenkins0 sites30 target enrollmentMay 22, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic obstructive pulmonary disease (COPD)
Sponsor
Dr. Sue Jenkins
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 22, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr. Sue Jenkins

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of COPD
  • Six\-minute walk distance \< 450 m prior to pulmonary rehabilitation
  • Deemed approp for a wheeled walker by a physiotherapist

Exclusion Criteria

  • use of a wheeled walker for more than 2 weeks prior to commencing pulmonary rehabilitation
  • any co\-morbid condition that limits mobility

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Can changing the way people with chronic lung disease think about breathlessness improve and sustain health outcomes?breathlessnessRespiratory - Chronic obstructive pulmonary diseasePublic Health - Health promotion/educationPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitation
ACTRN12611000292976niversity of South Australia120
Recruiting
Not Applicable
Electronic Snapshot for Outpatient Management of Chronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseasePublic Health - Health service research
ACTRN12614000296639The Prince Charles Hospital200
Completed
Not Applicable
sing behaviour change interventions to reduce sedentary time in people with chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary disease
ACTRN12619000856112Curtin University10
Not yet recruiting
Phase 3
Combined corticosteroid and long-acting beta-agonist versus corticosteroid for moderate/severe chronic obstructive pulmonary disease. A double blind, randomized, multicenter, phase III study.COPD (Chronic obstructive pulmonary disease)Respiratory - Chronic obstructive pulmonary disease
ACTRN12609000850279Aché Laboratories136
Not yet recruiting
Not Applicable
Prevalence of chronic obstructive pulmonary disease and asthma in the community of Pathumthani, ThailandAsthmaCOPDAsthmaCOPDPrevalenceLung function
TCTR20230711002Thailand Science Research and Innovation1,080